TFBS Bioscience (ROCO:6939) Short-Term Debt: NT$100.4 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6939 TFBS Bioscience Inc ROCO:6939
54 GF Score
Price NT$20.00
GF Value NT$29.90
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is TFBS Bioscience Short-Term Debt?

TFBS Bioscience ROCO:6939 +1.27% 54 Short-Term Debt is NT$100.4 Mil as of Jun. 2026. GuruFocus rates ROCO:6939 with a GF Score™ of 54/100 and a GF Value™ of NT$29.90 (Possible Value Trap). The stock has 6 warning signs investors should review.

TFBS Bioscience's Short-Term Debt for the quarter that ended in Jun. 2026 was NT$100.4 Mil.

TFBS Bioscience's quarterly Short-Term Debt stayed the same from Jun. 2025 (NT$100.4 Mil) to Dec. 2025 (NT$100.4 Mil) and stayed the same from Dec. 2025 (NT$100.4 Mil) to Jun. 2026 (NT$100.4 Mil).

TFBS Bioscience's annual Short-Term Debt increased from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$90.0 Mil) and increased from Dec. 2024 (NT$90.0 Mil) to Dec. 2025 (NT$100.4 Mil).

TFBS Bioscience Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

TFBS Bioscience Short-Term Debt Related Terms

TFBS Bioscience Short-Term Debt Historical Data

* Premium members only.

The historical data trend for TFBS Bioscience's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience Short-Term Debt Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 0.28 0.00 0.00 90.00 100.40

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 90.00 100.40 100.40 100.40
ROCO:6939
54GF Score
TFBS Bioscience Inc ROCO:6939
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NT$100.4 Mil mean?
TFBS Bioscience (ROCO:6939) has a Short-Term Debt of NT$100.4 Mil as of Jun. 2026.
Is TFBS Bioscience's Short-Term Debt too high?
TFBS Bioscience's current Short-Term Debt is NT$100.4 Mil. Overall, TFBS Bioscience has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's Short-Term Debt compare to TMO and DHR?
TFBS Bioscience's Short-Term Debt of NT$100.4 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. TFBS Bioscience's current Short-Term Debt is NT$100.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.90, compared to a current price of NT$20.00 — trading 33.1% below its estimated fair value. The current Short-Term Debt is NT$100.4 Mil. TFBS Bioscience's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current Short-Term Debt is NT$100.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?

Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued. The current stock price of NT$20.00 is trading 33.1% below its estimated GF Value™ of NT$29.90. GuruFocus considers TFBS Bioscience to be Possible Value Trap.

Key valuation signals for ROCO:6939:

  • Short-Term Debt: NT$100.4 Mil
  • GF Value™: NT$29.90 vs. price of NT$20.00 (33.1% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TFBS Bioscience Business Description

Address No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
54GF Score

Get the complete analysis for ROCO:6939

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.00
Price
NT$29.90
GF Value